Decision-making for prenatal genetic screening: how will pregnant women navigate a growing number of aneuploidy and carrier screening options?
Abstract Background Prenatal genetic screens, including carrier screening (CS) and aneuploidy screening (AS), comprise an important component of reproductive healthcare delivery. Clinical practice guidelines emphasize the importance of informed decision-making and patient’s preferences regarding the...
Guardado en:
Autores principales: | Ruth M. Farrell, Madelyn Pierce, Christina Collart, Meng Yao, Marissa Coleridge, Edward K. Chien, Susannah S. Rose, Mary Lintel, Uma Perni, Brownsyne Tucker Edmonds |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dbb2d6cf7812406a8b3f093caefb92e8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genetics for the Women's Health Trainee: A Five-Module Curriculum
por: Sarah K. Dotters-Katz, et al.
Publicado: (2019) -
Assessment of a change of protocol of prenatal screening by inclusion of non-invasive prenatal diagnosis
por: Cabra-Rodríguez Rocío, et al.
Publicado: (2020) -
Trends in Non-invasive Prenatal Screening and Invasive Testing in Denmark (2000–2019) and Israel (2011–2019)
por: Lena Sagi-Dain, et al.
Publicado: (2021) -
Clinical Application of Noninvasive Prenatal Testing for Pregnant Women with Assisted Reproductive Pregnancy
por: Jin XX, et al.
Publicado: (2021) -
DIAGNOSTICO PRENATAL DE SITUS INVERSUS TOTALIS
por: Paublo M,Mario, et al.
Publicado: (2002)